Regenerative Therapies For Osteoarthritis Market Report 2026

Regenerative Therapies For Osteoarthritis Market Overview

• Regenerative Therapies For Osteoarthritis market size has reached to $3.04 billion in 2025 • Expected to grow to $5.88 billion in 2030 at a compound annual growth rate (CAGR) of 14.2% • Growth Driver: Increasing Prevalence Of Musculoskeletal Disorders Driving The Market Growth Due To Rising Aging Population • Market Trend: Innovations In Regenerative Cell Therapies Advance Disease-Modifying Treatment For Osteoarthritis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Regenerative Therapies For Osteoarthritis Market?

Regenerative therapies for osteoarthritis refer to advanced medical treatments that aim to repair, regenerate, or replace damaged cartilage and joint tissues rather than just relieving symptoms. These therapies use biological approaches such as stem cells, platelet-rich plasma (PRP), growth factors, and tissue-engineered products to promote natural healing, reduce inflammation, restore joint function, and potentially slow or reverse the progression of osteoarthritis. The main therapy types of regenerative therapies for osteoarthritis are stem cell therapy, platelet rich plasma therapy, tissue engineering, gene therapy, and other therapy types. Stem cell therapy refers to treatments that use stem cells to repair or regenerate damaged cartilage and tissues in osteoarthritis-affected joints. These therapies are delivered through various distribution channels, including direct manufacturer supply, hospital and clinic procurement channels, and specialty medical distributors. They are applied to different applications, such as knee osteoarthritis, hip osteoarthritis, hand osteoarthritis, and other applications, and are used by multiple end-users, including hospitals, ambulatory surgical centers, specialty clinics, and other end-users.

What Is The Regenerative Therapies For Osteoarthritis Market Growth Forecast?

The regenerative therapies for osteoarthritis market size is expected to see rapid growth in the next few years. It will grow to $5.88 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to growth in biologic therapy adoption, expansion of regenerative clinics, increasing clinical evidence support, rising demand for cartilage restoration, higher investment in cell therapy research. Major trends in the forecast period include stem cell based joint repair therapies, platelet rich plasma treatment protocols, scaffold based cartilage regeneration, minimally invasive regenerative injections, personalized biologic therapy plans.

Global Regenerative Therapies For Osteoarthritis Market Segmentation

1) By Therapy Type: Stem Cell Therapy; Platelet Rich Plasma Therapy; Tissue Engineering; Gene Therapy; Other Therapy Types 2) By Distribution Channel: Direct Manufacturer Supply; Hospital And Clinic Procurement Channels; Specialty Medical Distributors 3) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis; Other Applications 4) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End Users Subsegments: 1) By Stem Cell Therapy: Autologous Stem Cell Therapy; Allogeneic Stem Cell Therapy; Mesenchymal Stem Cell Therapy; Adipose Derived Stem Cell Therapy; Bone Marrow Derived Stem Cell Therapy 2) By Platelet Rich Plasma Therapy: Leukocyte Rich Platelet Rich Plasma Therapy; Leukocyte Poor Platelet Rich Plasma Therapy; Activated Platelet Rich Plasma Therapy; Non Activated Platelet Rich Plasma Therapy; Pure Platelet Rich Plasma Therapy 3) By Tissue Engineering: Scaffold Based Tissue Engineering; Hydrogel Based Tissue Engineering; Biodegradable Matrix Tissue Engineering; Cell Seeded Tissue Engineering; Three Dimensional Tissue Engineering 4) By Gene Therapy: Viral Vector Gene Therapy; Non Viral Vector Gene Therapy; In Vivo Gene Therapy; Ex Vivo Gene Therapy; Targeted Gene Therapy 5) By Other Therapy Types: Hyaluronic Acid Therapy; Growth Factor Therapy; Chondrocyte Implantation Therapy; Peptide Based Therapy; Immunomodulatory Therapy

What Is The Driver Of The Regenerative Therapies For Osteoarthritis Market?

The increasing prevalence of musculoskeletal disorders is expected to propel the growth of the regenerative therapies for the osteoarthritis market going forward. Musculoskeletal disorders are conditions affecting bones, joints, muscles, and connective tissues that cause pain and limitations in mobility and dexterity. The growing prevalence of musculoskeletal disorders is largely driven by population aging, as older age groups experience higher rates of joint degeneration and inflammatory conditions that affect musculoskeletal structures. The rising incidence of musculoskeletal disorders boosts demand for regenerative therapies as they offer advanced treatment options for joint restoration and tissue repair in osteoarthritis patients. For instance, in January 2024, according to the Office for Health Improvement & Disparities, a UK-based government agency, in 2023, 18.4% of individuals aged 16 and above reported having a long-term musculoskeletal (MSK) condition, reflecting an increase from 17.6% in 2022. Therefore, the increasing prevalence of musculoskeletal disorders is driving the growth of the regenerative therapies for the osteoarthritis market.

Key Players In The Global Regenerative Therapies For Osteoarthritis Market

Major companies operating in the regenerative therapies for osteoarthritis market are Stryker Corporation, Smith & Nephew plc, MiMedx Group Inc, Anika Therapeutics Inc, Regentis Biomaterials Ltd, Zomedica Corp, Biosplice Therapeutics Inc, Tissue Regenix Group plc, Co.don AG, MEDIPOST Co Ltd, Ampio Pharmaceuticals Inc, Kolon TissueGene Inc, Mesoblast Limited, Orgenesis Inc, Hyalex Orthopaedics Limited, Orthocell Limited, Jellagen Limited, Hyalogic LLC, Bionaut Labs Inc, and Regeneus Limited.

Global Regenerative Therapies For Osteoarthritis Market Trends and Insights

Major companies operating in the regenerative therapies for the osteoarthritis market are focusing on developing advanced solutions, such as allogeneic mesenchymal stem cell (MSC) osteoarthritis therapies, to meet the rising demand for disease-modifying treatments. Allogeneic mesenchymal stem cell (MSC) osteoarthritis therapies use donor-sourced stem cells to modulate inflammation and support cartilage regeneration in affected joints, providing a ready-to-use, scalable option compared with patient-derived cells, allowing standardized dosing and wider adoption. For instance, in December 2025, Cipla Limited, an India-based pharmaceutical company, partnered with Stempeutics Research, an India-based research and product development company, to launch Ciplostem, an innovative allogeneic MSC therapy for knee osteoarthritis. It is administered as a single-dose intra-articular injection containing 25 million cultured adult human bone marrow-derived MSCs co-formulated with hyaluronic acid, designed to work at the cellular level to reduce inflammation, slow disease progression, enhance joint function, and help preserve cartilage quality in Grade II and III knee OA patients. This therapy’s key features include off-the-shelf availability (no need for individualized preparation), cellular-level action versus symptomatic relief, and potential for prolonged improvement in joint health compared with standard regimens.

What Are Latest Mergers And Acquisitions In The Regenerative Therapies For Osteoarthritis Market?

In January 2024, Smith+Nephew, a UK-based medical technology company, acquired CartiHeal for an undisclosed amount. Through this acquisition, Smith+Nephew aims to strengthen its sports medicine business by expanding its regenerative knee repair portfolio with advanced cartilage regeneration technologies for osteochondral lesions and osteoarthritis treatment. CartiHeal is an Israel-based healthcare technology company that specializes in developing Agili-C, a sports medicine technology for cartilage regeneration in the knee.

Regional Insights

North America was the largest region in the regenerative therapies for osteoarthritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Regenerative Therapies For Osteoarthritis Market?

The regenerative therapies for osteoarthritis market includes revenues earned by entities through clinical consultation, patient assessment, therapy administration, regenerative cell preparation, tissue engineering support, post-treatment monitoring, rehabilitation support, laboratory testing, personalized treatment planning, and regulatory compliance support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Regenerative Therapies For Osteoarthritis Market Report 2026?

The regenerative therapies for osteoarthritis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the regenerative therapies for osteoarthritis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.